Trial Profile
Phase II trial of sapacitabine for solid tumours.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 31 Dec 2012
Price :
$35
*
At a glance
- Drugs Sapacitabine (Primary)
- Indications Breast cancer; Lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Cyclacel Pharmaceuticals
- 31 Dec 2012 New trial record